These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 762131)

  • 21. The activation of bovine protein C by factor Xa.
    Haley PE; Doyle MF; Mann KG
    J Biol Chem; 1989 Sep; 264(27):16303-10. PubMed ID: 2550435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemically modified bovine prothrombin as a substrate in studies of activation kinetics and fluorescence changes during thrombin formation.
    Silverberg SA
    J Biol Chem; 1980 Sep; 255(18):8550-9. PubMed ID: 7410376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic alterations of factor Va bound to platelets.
    Tracy PB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Jan; 258(1):662-9. PubMed ID: 6848522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that the thrombin-catalyzed feedback cleavage of fragment 1.2 at Arg154-Ser155 promotes the release of thrombin from the catalytic surface during the activation of bovine prothrombin.
    Nesheim ME; Abbott T; Jenny R; Mann KG
    J Biol Chem; 1988 Jan; 263(2):1037-44. PubMed ID: 3422076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.
    Nesheim ME; Canfield WM; Kisiel W; Mann KG
    J Biol Chem; 1982 Feb; 257(3):1443-7. PubMed ID: 6895752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic intermediates in prothrombin activation. Bovine prethrombin 1 conversion to thrombin by factor X.
    Carlisle TL; Bock PE; Jackson CM
    J Biol Chem; 1990 Dec; 265(35):22044-55. PubMed ID: 2254347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.
    Salem HH; Broze GJ; Miletich JP; Majerus PW
    J Biol Chem; 1983 Jul; 258(14):8531-4. PubMed ID: 6688078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity.
    Esmon CT
    J Biol Chem; 1979 Feb; 254(3):964-73. PubMed ID: 762106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.
    Tracy PB; Mann KG
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2380-4. PubMed ID: 6572981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of human coagulation factor V.
    Kane WH; Majerus PW
    J Biol Chem; 1981 Jan; 256(2):1002-7. PubMed ID: 7451453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolysis of factor Va by factor Xa and activated protein C.
    Odegaard B; Mann K
    J Biol Chem; 1987 Aug; 262(23):11233-8. PubMed ID: 3611108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factor V: a plethora of anticoagulant molecules.
    Kalafatis M
    Curr Opin Hematol; 2005 Mar; 12(2):141-8. PubMed ID: 15725905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.
    Majumder R; Weinreb G; Lentz BR
    Biochemistry; 2005 Dec; 44(51):16998-7006. PubMed ID: 16363813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombin fragments. Ca2+ binding and activation kinetics.
    Bajaj SP; Butkowski RJ; Mann KG
    J Biol Chem; 1975 Mar; 250(6):2150-6. PubMed ID: 1117001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.